A new analysis published today in the prestigious New England Journal of Medicine finds that the cost of providing transition-related health care for transgender service members will be minimal after the Pentagon lifts its ban. In "Caring for Our Transgender Troops-The Negligible Cost of Transition-Related Care," Dr. Aaron Belkin, Palm Center director and visiting professor at University of California, Hastings, concludes that the analysis should allay concerns about financial implications of inclusive policy. "Under any plausible estimation method," Belkin said, "the costs are minimal."
You can read more by clicking here.
You can read the analysis by clicking here.